Literature DB >> 9194803

Homocysteine, oxidative stress, and vascular disease.

G N Welch1, G R Upchurch, J Loscalzo.   

Abstract

First recognized in patients with rare inborn errors of metabolism, the association of elevated plasma homocysteine concentrations with atherosclerosis and thrombosis now seems relevant to the general population as well. The mechanism of injury appears to involve oxidative damage to endothelial cells. Vitamin supplementation can normalize homocysteine levels and may lower the incidence of atherothrombotic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194803     DOI: 10.1080/21548331.1997.11443510

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  23 in total

Review 1.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; Gary B Chapman; William Durante; Nicholas E S Sibinga; Andrew I Schafer
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 3.  Early developmental conditioning of later health and disease: physiology or pathophysiology?

Authors:  M A Hanson; P D Gluckman
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 4.  Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.

Authors:  Mesia M Steed; Suresh C Tyagi
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  Oxidative stress in coronary artery disease: epigenetic perspective.

Authors:  Sana Venkata Vijaya Lakshmi; Shaik Mohammad Naushad; Cheruku Apoorva Reddy; Kankanala Saumya; Damera Seshagiri Rao; Srigiridhar Kotamraju; Vijay Kumar Kutala
Journal:  Mol Cell Biochem       Date:  2012-11-17       Impact factor: 3.396

Review 6.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

7.  Pretreatment with vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats.

Authors:  Eleonora A Reis; Alexandra I Zugno; Renata Franzon; Bárbara Tagliari; Cristiane Matté; Marcelo L Lammers; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

8.  Reduction of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia.

Authors:  Emílio L Streck; Cristiane Matte; Paula S Vieira; Fernanda Rombaldi; Clóvis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

9.  Inhibition of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment.

Authors:  Angela T S Wyse; Alexandra I Zugno; Emilio L Streck; Cristiane Matté; Thiago Calcagnotto; Clovis M D Wannmacher; Moacir Wajner
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

10.  Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives.

Authors:  R Pandey; S Gupta; H Lal; H C Mehta; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.